FDA product code · Microbiology

Anti-Streptokinase

Name: FDA decisions, review times, recalls and adverse event reports for product code GTO
Creator: 510(k) Report

GTOClass I21 CFR 866.3720510(k) exempt0 decisions0 recalls

FDA lists GTO as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 866.9 applies, such as a new intended use or a different fundamental technology. 0 FDA decisions. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, microbiology panel

Twenty years of GTO at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FIG. 1 — GTO by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in GTO? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 866.3720.

LHW Erythrocyte Suspension, Multi Species…GTQ Antistreptolysin - Titer/Streptolysin O Reagent GTR Antideoxyribonuclease, Streptococcus Spp.GTP Exoenzymes, Multiple, Streptococcal